PTC vs ZNTL · P/E 48, rev $2.74B vs $257.7M cap
PTC Inc (PTC) versus Zentalis Pharmaceuticals Llc (ZNTL) — a side-by-side from cached financials, not a winner call.
PTC Inc (PTC) is a software - application company listed on US.
Zentalis Pharmaceuticals Llc (ZNTL) is a biotechnology company listed on NASDAQ.
Latest reported PTC revenue for 2025-09-30 was $2.74B. Net income was $734.0M. PTC currently screens at market cap $21.11B and trailing P/E 48.3.
Latest reported ZNTL revenue for 2025-09-30 was $0. Net income was -$26.7M. ZNTL currently screens at market cap $257.7M.
PTC currently screens at market cap $21.11B and trailing P/E 48.3. ZNTL currently screens at market cap $257.7M.
Not investment advice. Open the PTC and ZNTL stock pages for the full models.
Not investment advice.